Mereo Stock Technical Analysis

MREO
 Stock
  

USD 1.15  0.06  4.96%   

As of the 12th of August 2022, Mereo Biopharma secures the Downside Deviation of 7.46, mean deviation of 7.8, and Risk Adjusted Performance of 0.2428. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mereo Biopharma Group, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Mereo Biopharma, which can be compared to its peers in the industry. Please verify Mereo Biopharma Group variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Mereo Biopharma Group is priced some-what accurately, providing market reflects its recent price of 1.15 per share. Given that Mereo Biopharma Group is a hitting penny stock territory we strongly suggest to closely look at its total risk alpha.
  

Mereo Biopharma Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Mereo, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Mereo
Mereo Biopharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Mereo Biopharma Analyst Consensus

Target PriceAdvice# of Analysts
9.0Buy2Odds
Mereo Biopharma Group current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Mereo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mereo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mereo Biopharma Group, talking to its executives and customers, or listening to Mereo conference calls.
Mereo Analyst Advice Details
Mereo Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Mereo Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Mereo Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Mereo Biopharma Group Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-five with a total number of output elements of thirty-six. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Mereo Biopharma Group volatility. High ATR values indicate high volatility, and low values indicate low volatility.
.

Mereo Biopharma Group Trend Analysis

Use this graph to draw trend lines for Mereo Biopharma Group. You can use it to identify possible trend reversals for Mereo Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Mereo Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Mereo Biopharma Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Mereo Biopharma Group applied against its price change over selected period. The best fit line has a slop of   0.017275  , which means Mereo Biopharma Group will continue generating value for investors. It has 122 observation points and a regression sum of squares at 11.29, which is the sum of squared deviations for the predicted Mereo Biopharma price change compared to its average price change.

About Mereo Biopharma Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Mereo Biopharma Group on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Mereo Biopharma Group based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Mereo Biopharma Group stock first instead of the macroeconomic environment surrounding Mereo Biopharma Group. By analyzing Mereo Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Mereo Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Mereo Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2010 2021 (projected)
null0.350.31
null0.510.46

Mereo Biopharma August 12, 2022 Technical Indicators

Most technical analysis of Mereo help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Mereo from various momentum indicators to cycle indicators. When you analyze Mereo charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Mereo Biopharma August 12, 2022 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Mereo stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Additionally, see Stocks Correlation. Note that the Mereo Biopharma Group information on this page should be used as a complementary analysis to other Mereo Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Mereo Stock analysis

When running Mereo Biopharma Group price analysis, check to measure Mereo Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo Biopharma is operating at the current time. Most of Mereo Biopharma's value examination focuses on studying past and present price action to predict the probability of Mereo Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mereo Biopharma's price. Additionally, you may evaluate how the addition of Mereo Biopharma to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Is Mereo Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mereo Biopharma. If investors know Mereo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mereo Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
138 M
Return On Assets
-0.14
Return On Equity
0.35
The market value of Mereo Biopharma Group is measured differently than its book value, which is the value of Mereo that is recorded on the company's balance sheet. Investors also form their own opinion of Mereo Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Mereo Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mereo Biopharma's market value can be influenced by many factors that don't directly affect Mereo Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mereo Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Mereo Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mereo Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.